Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H38O4 |
| Molecular Weight | 378.5454 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](C)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
InChI
InChIKey=OOAHNJDZICJECC-BHWPLRMJSA-N
InChI=1S/C23H38O4/c1-5-6-15-23(3,4)21(25)14-13-18-17(2)16-20(24)19(18)11-9-7-8-10-12-22(26)27/h7,9,13-14,17-19,21,25H,5-6,8,10-12,15-16H2,1-4H3,(H,26,27)/b9-7-,14-13+/t17-,18+,19-,21-/m1/s1
| Molecular Formula | C23H38O4 |
| Molecular Weight | 378.5454 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 2 |
| Optical Activity | UNSPECIFIED |
Trimoprostil is a synthetic prostaglandin E2 derivative and prostanoid receptor agonist, with potential gastric secretion inhibitor and antiulcerogenic activity. It has been shown to reduce hydrogen ion secretion, to enhance gastric bicarbonate secretion and to reduce aspirin-induced gastric mucosal injury. In contrast to many E prostaglandins, it does not lower the tone of the lower oesophageal sphincter. Trimoprostil was well tolerated and more effective than placebo in the treatment of mild to moderate symptomatic reflux oesophagitis. It may be protective to human squamous oesophageal mucosa. Trimoprostil was not as effective as cimetidine in the treatment of duodenal ulcer.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins. | 1989-06 |
|
| [Prostaglandin analogues in the treatment of peptic ulcer disease]. | 1989-01-09 |
|
| Treatment of reflux oesophagitis with trimoprostil. | 1989 |
|
| The effects of prostaglandins on gastric emptying. | 1989 |
|
| The effect of trimoprostil (trimethyldesoxy prostaglandin E2) on the intrauterine pressure in women. | 1988-08 |
|
| Effect of trimoprostil on gastric secretion in man. | 1988-06 |
|
| Effect of a slow-release formula of trimoprostil on intragastric acidity in healthy volunteers. | 1988-04 |
|
| A multicentre comparison of trimoprostil and cimetidine in the treatment of duodenal ulcer. U.K. Trimoprostil Study Collaborative Group. | 1988-03 |
|
| [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins]. | 1988-01 |
|
| Double-blind study comparing cimetidine and two doses of a slow release formulation of trimoprostil in duodenal ulcer patients with a 6-month follow-up. | 1988 |
|
| Effects of acute administration of a prostaglandin E2 analog, trimoprostil, on esophageal motility in man. | 1987-09 |
|
| Pharmacokinetics and antisecretory activity of trimoprostil in Heidenhain-pouch dogs. | 1987-05 |
|
| Biliary, fecal and urinary excretion of [3H]-prostaglandins in the rat. | 1987-03 |
|
| Effects of trimoprostil, a prostaglandin E2 analogue, on human gastric acid secretion and soluble mucin output. | 1987-02 |
|
| Prostaglandins in clinical treatment of gastroduodenal mucosal lesions: a review. | 1987 |
|
| Effects of trimoprostil on healing and recurrence of acetic acid-induced gastric ulcer in rats. | 1986-12 |
|
| Specificity of PGE2 analogs interaction between food intake and antisecretory effect. | 1986-10 |
|
| Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation. | 1986-07-01 |
|
| [Intragastric acidity under the prostaglandin E2 analog trimoprostil. Increased inhibitory effect through administration after meals]. | 1986-03 |
|
| Current concepts in clinical therapeutics: peptic ulcer disease. | 1986-02 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:45 GMT 2025
by
admin
on
Mon Mar 31 17:56:45 GMT 2025
|
| Record UNII |
4DVL1781YC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29701
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
||
|
NCI_THESAURUS |
C78568
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000076946
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
SUB11315MIG
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
4DVL1781YC
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
DTXSID201021722
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
m11165
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | Merck Index | ||
|
Y-66
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
5298
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
6917757
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
C152748
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104498
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY | |||
|
69900-72-7
Created by
admin on Mon Mar 31 17:56:45 GMT 2025 , Edited by admin on Mon Mar 31 17:56:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |